Lung Injury Prediction Study

Acute Lung Injury Clinical Trial

— USCTG-LIPS1  

Official title:

Identifying Patients at Risk of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) at the Time of Hospital Admission: External Validation of a Lung Injury Prediction Score (LIPS)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00889772
• Other study ID #: 08-008726
• Secondary ID: USCIITG-LIPS1
• Status: Completed
• Phase: N/A
• First received: April 27, 2009
• Last updated: September 22, 2015
• Start date: March 2009
• Est. completion date: February 2010

Study information

• Verified date: June 2012
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review BoardTurkey: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to externally validate the acute lung injury/acute respiratory distress syndrome (ALI/ARDS) prediction model (Lung Injury Prediction Score - LIPS) in a multicenter sample of patients at risk presented to the acute care hospitals: United States Critical Illness and Injury Trials Group (USCIITG).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: February 2010
• Est. primary completion date: February 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Hospitalized adult patients with one of the known risk factors for acute lung injury at the time of hospital admission

Exclusion Criteria:

• ALI/ARDS already present at the time of hospital admission, denied use of medical records for research, children, hospital readmission, transfer from another hospital

Study Design

Observational Model: Cohort

Related Conditions & MeSH terms

• Acute Lung Injury
• Lung Injury
• Respiratory Distress
• Respiratory Distress Syndrome, Adult

Locations

Country	Name	City	State
United States	Mayo Clinic	Rochester	Minnesota

Sponsors (21)

Lead Sponsor

Collaborator

Mayo Clinic

Akdeniz University, Beth Israel Deaconess Medical Center, Boston University, Bridgeport Hospital, Brigham and Women's Hospital, Icahn School of Medicine at Mount Sinai, Johns Hopkins University, Massachusetts General Hospital, Providence Regional Medical Center, Temple University, Uludag University, University of Colorado, Denver, University of Illinois at Chicago, University of Medicine and Dentistry of New Jersey, University of Michigan, University of Missouri-Columbia, University of Pennsylvania, University of Texas Southwestern Medical Center, Wake Forest University, Wright State University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acute Lung Injury or Acute Respiratory Distress Syndrome		during hospital stay	No
Secondary	Survival		in hospital	No